Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion

Toxicological Sciences

Volumn 131, Issue 2, 2013, Pages 375-386

  Lempiäinen, Harri ^a   Couttet, Philippe ^a   Bolognani, Federico ^a   Müller, Arne ^a   Dubost, Valérie ^a   Luisier, Raphaëlle ^a   Espinola, Alberto Del Rio ^a   Vitry, Veronique ^a   Unterberger, Elif B ^b   Thomson, John P ^c   Treindl, Fridolin ^d   Metzger, Ute ^d   Wrzodek, Clemens ^b   Hahne, Florian ^a   Zollinger, Tulipan ^a   Brasa, Sarah ^a   Kalteis, Magdalena ^a   Marcellin, Magali ^a   Giudicelli, Fanny ^a   Braeuning, Albert ^b   Morawiec, Laurent ^a   Zamurovic, Natasa ^a   Längle, Ulrich ^a   Scheer, Nico ^e   Schübeler, Dirk ^f   Goodman, Jay ^g   Chibout, Salah Dine ^a   Marlowe, Jennifer ^a   Theil, Diethilde ^a   Heard, David J ^a   Grenet, Olivier ^a   Zell, Andreas ^b   Templin, Markus F ^d   Meehan, Richard R ^c   Wolf, Roland C ^h,i   Elcombe, Clifford R ^h   Schwarz, Michael ^b   Moulin, Pierre ^a   Terranova, Rémi ^a   Moggs, Jonathan G ^a   more..

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e TaconicArtemis   (Germany)

^f FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^g MICHIGAN STATE UNIVERSITY   (United States)

^h CXR Biosciences Ltd   (United Kingdom)

ⁱ UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Biomarker; Dlk1 Dio3 imprinted cluster; Epigenetics; Noncoding RNAs; Nongenotoxic carcinogenesis; Phenobarbital

Indexed keywords

BETA CATENIN; CONSTITUTIVE ANDROSTANE RECEPTOR; DIO3 PROTEIN; DLK1 PROTEIN; GLUTAMATE AMMONIA LIGASE; MESSENGER RNA; MICRORNA; PHENOBARBITAL; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DISEASE MARKER; DISEASE SEVERITY; DNA METHYLATION; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENOME IMPRINTING; IN VIVO STUDY; LIVER HYPERTROPHY; LIVER TUMOR; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

ANIMALS; BETA CATENIN; FEMALE; GENOMIC IMPRINTING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IODIDE PEROXIDASE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84873844990     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs303     Document Type: Article

References (72)

1. Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., and Schwarz, M. (2001). Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 20, 7812-7816.
2. Bachman, A. N., Phillips, J. M., and Goodman, J. I. (2006). Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol. Sci. 91, 393-405.
3. Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Becker, F. F. (1982). Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res. 42, 3918-3923.
5. Benjamini, Y., and Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300.
6. Berdasco, M., and Esteller, M. (2010). Aberrant epigenetic landscape in cancer: How cellular identity goes awry. Dev. Cell 19, 698-711.
7. Bonnet, D., and Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
8. Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., and Patel, T. (2011). microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30, 4750-4756.
9. Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stemlike state. Proc. Natl. Acad. Sci. U.S.A. 108, 7950-7955.
10. Chen, L. L., and Carmichael, G. G. (2010). Decoding the function of nuclear long non-coding RNAs. Curr. Opin. Cell Biol. 22, 357-364.
11. Counts, J. L., Sarmiento, J. I., Harbison, M. L., Downing, J. C., McClain, R. M., and Goodman, J. L. (1996). Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis 17, 1251-1257.
12. Dyer, M. A., and Bremner, R. (2005). The search for the retinoblastoma cell of origin. Nat. Rev. Cancer 5, 91-101.
13. Elcombe, C. R., Odum, J., Foster, J. R., Stone, S., Hasmall, S., Soames, A. R., Kimber, I., and Ashby, J. (2002). Prediction of rodent nongenotoxic carcinogenesis: Evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ. Health Perspect. 110, 363-375.
14. Eppig, J. T., Blake, J. A., Bult, C. J., Kadin, J. A., and Richardson, J. E. (2012). The Mouse Genome Database (MGD): Comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 40, D881-D886.
15. Esteller, M., and Rodriguez-Paredes, M. (2011). Cancer epigenetics reaches mainstream oncology. Nat. Med. 17, 330-339.
16. Feinberg, A. P., Ohlsson, R., and Henikoff, S. (2006). The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33.
17. Gariboldi M, Manenti G, Canzian F, et al. (1993). Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53, 209-11.
18. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004). Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 5, R80.
19. Goodman, J. I., and Watson, R. E. (2002). Altered DNA methylation: A secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42, 501-525.
20. Gournay, J., Auvigne, I., Pichard, V., Ligeza, C., Bralet, M. P., and Ferry, N. (2002). In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: Evidence for dedifferentiation of mature hepatocytes. Lab. Invest. 82, 781-788.
21. Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., et al. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300.
22. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell 144, 646-674.
23. Hartmann, M., Roeraade, J., Stoll, D., Templin, M. F., and Joos, T. O. (2009). Protein microarrays for diagnostic assays. Anal. Bioanal. Chem. 393, 1407-1416.
24. Hasmall, S. C., and Roberts, R. A. (1999). The perturbation of apoptosis and mitosis by drugs and xenobiotics. Pharmacol. Ther. 82, 63-70.
25. Hoflack, J. C., Mueller, L., Fowler, S., Braendli-Baiocco, A., Flint, N., Kuhlmann, O., Singer, T., and Roth, A. (2012). Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: The dalcetrapib experience. Toxicol. Appl. Pharmacol. 259, 355-365.
26. Holsapple, M. P., Pitot, H. C., Cohen, S. M., Cohen, S. H., Boobis, A. R., Klaunig, J. E., Pastoor, T., Dellarco, V. L., and Dragan, Y. P. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci. 89, 51-56.
27. Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., and Moore, D. D. (2005). Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol. Endocrinol. 19, 1646-1653.
28. IARC. (2001). Phenobarbital and its sodium salt. IARC Monogr. 79, 161-286.
29. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U., and Speed, T. P. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
30. Jones, P. A., and Baylin, S. B. (2007). The epigenomics of cancer. Cell 128, 683-692.
31. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K., and Negishi, M. (1999). Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19, 6318-6322.
32. Keane, T. M., Goodstadt, L., Danecek, P., White, M. A., Wong, K., Yalcin, B., Heger, A., Agam, A., Slater, G., Goodson, M., et al. (2011). Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477, 289-294.
33. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 11667-11672.
34. Koerner, M. V., Pauler, F. M., Huang, R., and Barlow, D. P. (2009). The function of non-coding RNAs in genomic imprinting. Development 136, 1771-1783.
35. Kostka, G., Urbanek, K., and Ludwicki, J. K. (2007). The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver. Toxicology 239, 127-135.
36. Koturbash, I., Beland, F. A., and Pogribny, I. P. (2011). Role of epigenetic events in chemical carcinogenesis-a justification for incorporating epigenetic evaluations in cancer risk assessment. Toxicol. Mech. Methods 21, 289-297.
37. Lamminpaa, A., Pukkala, E., Teppo, L., and Neuvonen, P. J. (2002). Cancer incidence among patients using antiepileptic drugs: A long-term follow-up of 28,000 patients. Eur. J. Clin. Pharmacol. 58, 137-141.
38. LeBaron, M. J., Rasoulpour, R. J., Klapacz, J., Ellis-Hutchings, R. G., Hollnagel, H. M., and Gollapudi, B. B. (2010). Epigenetics and chemical safety assessment. Mutat. Res. 705, 83-95.
39. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023.
40. Lempiainen, H., Müller, A., Brasa, S., Teo, S. S., Roloff, T. C., Morawiec, L., Zamurovic, N., Vicart, A., Funhoff, E., Couttet, P., et al. (2011). Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice. PLoS ONE 6, e18216
41. Liu, L., Luo, G. Z., Yang, W., Zhao, X., Zheng, Q., Lv, Z., Li, W., Wu, H. J., Wang, L., Wang, X. J., et al. (2010). Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J. Biol. Chem. 285, 19483-19490.
42. Loeppen, S., Schneider, D., Gaunitz, F., Gebhardt, R., Kurek, R., Buchmann, A., and Schwarz, M. (2002). Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. 62, 5685-5688.
43. Luk, J. M., Burchard, J., Zhang, C., Liu, A. M., Wong, K. F., Shek, F. H., Lee, N. P., Fan, S. T., Poon, R. T., Ivanovska, I., et al. (2011). DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J. Biol. Chem. 286, 30706-30713.
44. Merlo, L. M., Pepper, J. W., Reid, B. J., and Maley, C. C. (2006). Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935.
45. Negrini, S., Gorgoulis, V. G., and Halazonetis, T. D. (2010). Genomic instability- an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220-228.
46. Parzefall, W., Erber, E., Sedivy, R., and Schulte-Hermann, R. (1991). Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51, 1143-1147.
47. Phillips, J. M., Burgoon, L. D., and Goodman, J. I. (2009a). The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. Toxicol. Sci. 110, 319-333.
48. Phillips, J. M., Burgoon, L. D., and Goodman, J. I. (2009b). Phenobarbital elicits unique, early changes in the expression of hepatic genes that affect critical pathways in tumor-prone B6C3F1 mice. Toxicol. Sci. 109, 193-205.
49. Phillips, J. M., and Goodman, J. I. (2008). Identification of genes that may play critical roles in phenobarbital (PB)-induced liver tumorigenesis due to altered DNA methylation. Toxicol. Sci. 104, 86-99.
50. Phillips, J. M., Yamamoto, Y., Negishi, M., Maronpot, R. R., and Goodman, J. I. (2007). Orphan nuclear receptor constitutive active/androstane receptormediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis. Toxicol. Sci. 96, 72-82.
51. Pirttiaho, H. I., Sotaniemi, E. A., Pelkonen, R. O., and Pitkänen, U. (1982). Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur. J. Clin. Pharmacol. 22, 441-445.
52. Prasanth, K. V., and Spector, D. L. (2007). Eukaryotic regulatory RNAs: An answer to the 'genome complexity' conundrum. Genes Dev. 21, 11-42.
53. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
54. Rignall, B., Braeuning, A., Buchmann, A., and Schwarz, M. (2011). Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/ phenobarbital tumor promotion regimen. Carcinogenesis 32, 52-57.
55. Ross, J., Plummer, S. M., Rode, A., Scheer, N., Bower, C. C., Vogel, O., Henderson, C. J., Wolf, C. R., and Elcombe, C. R. (2010). Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol. Sci. 116, 452-466.
56. Sato, S., Yoshida, W., Soejima, H., Nakabayashi, K., and Hata, K. (2011). Methylation dynamics of IG-DMR and Gtl2-DMR during murine embryonic and placental development. Genomics 98, 120-127.
57. Scheer, N., Ross, J., Rode, A., Zevnik, B., Niehaves, S., Faust, N., and Wolf, C. R. (2008). A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest. 118, 3228-3239.
58. Smyth, G. K. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article 3.
59. Smyth, G. K., Ed. (2005). Limma: Linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor, pp. 397-420. Springer, New York.
60. Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34, 146-152.
61. Spindler, P., van der Laan, J. W., Ceuppens, P., Harling, R., Ettlin, R., and Lima, B. S. (2000). Carcinogenicity testing of pharmaceuticals in the European Union: A workshop report. Drug Inf. J. 34: 821-828.
62. Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., Kono, T., Shioda, T., and Hochedlinger, K. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175-181.
63. Thayanithy, V., Sarver, A. L., Kartha, R. V., Li, L., Angstadt, A. Y., Breen, M., Steer, C. J., Modiano, J. F., and Subramanian, S. (2012). Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 50, 171-181.
64. Thomson, J. P., Lempiäinen, H., Hackett, J. A., Nestor, C. E., Müller, A., Bolognani, F., Oakeley, E. J., Schübeler, D., Terranova, R., Reinhardt, D., et al. (2012). Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol. 13, R93.
65. Tolson, A. H., and Wang, H. (2010). Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv. Drug Deliv. Rev. 62, 1238-1249.
66. Wang, P. R., Xu, M., Toffanin, S., Li, Y., Llovet, J. M., and Russell, D. W. (2012). Induction of hepatocellular carcinoma by in vivo gene targeting. Proc. Natl. Acad. Sci. U.S.A. 109, 11264-11269.
67. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. D. (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920-923.
68. Whysner, J., Ross, P. M., and Williams, G. M. (1996). Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71, 153-191.
69. Wrzodek, C., Schröder, A., Dräger, A., Wanke, D., Berendzen, K. W., Kronfeld, M., Harter, K., and Zell, A. (2010). ModuleMaster: A new tool to decipher transcriptional regulatory networks. BioSystems 99, 79-81.
70. Xie, W., Barr, C. L., Kim, A., Yue, F., Lee, A. Y., Eubanks, J., Dempster, E. L., and Ren, B. (2012). Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 148, 816-831.
71. Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., and Maronpot, R. R. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64, 7197-7200.
72. Zhao, J., Ohsumi, T. K., Kung, J. T., Ogawa, Y., Grau, D. J., Sarma, K., Song, J. J., Kingston, R. E., Borowsky, M., and Lee, J. T. (2010). Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939-953.